Drugs / YHD1023
last change Mar 2013 re-read 2 minutes ago

YHD1023

Developed for
erectile dysfunction
Investigated by
Yuhan Corporation

Trials 1 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01423370 Nov 2011 → Mar 2013 erectile dysfunction Yuhan Corporation Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as YHD1023 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01423370
Route Oral “5g oral once daily” NCT01423370